What is Ranibizumab?

Category: Prescription Drugs

Most popular types: Lucentis


Ranibizumab is a vascular endothelial growth factor (VEGF) inhibitor that is used for the treatment of Wet/Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Diabetic Macular Edema.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 0

Commonly reported side effects and conditions associated with Ranibizumab

Side effect Patients
Eye floaters 1
Eye pain 1
Joint pain 1
Sore throat 1


Currently taking Ranibizumab

Duration Patients
6 months - 1 year 1
Last updated:
There are no evaluations for Ranibizumab.